The Short-Term and Long-Term Effects of Cardiac Resynchronization Therapy in Heart Failure Patients
暂无分享,去创建一个
Ying Qin | Bin Zhang | Juan Wu | Jinxue Liu | Xue-fang Zhang | Gaoxing Zhang | Weidong Gao | Yucheng Peng | Qiang Ren | Gang Sun | Xue-fang Zhang | Gaoxing Zhang | Bin Zhang | Jinxue Liu | Juan Wu | Gang Sun | Yucheng Peng | Ying Qin | Weidong Gao | Qiang Ren
[1] J. Cleland,et al. Is the prognosis of heart failure improving? , 2000, European journal of heart failure.
[2] D. Delurgio,et al. Effect of Cardiac Resynchronization Therapy on Left Ventricular Size and Function in Chronic Heart Failure , 2003, Circulation.
[3] John G F Cleland,et al. Delivering the cumulative benefits of triple therapy to improve outcomes in heart failure: too many cooks will spoil the broth. , 2003, Journal of the American College of Cardiology.
[4] J. Conti,et al. Use of cardiac resynchronization therapy to optimize beta-blocker therapy in patients with heart failure and prolonged QRS duration. , 2005, The American journal of cardiology.
[5] J. Daubert,et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. , 2005, The New England journal of medicine.
[6] Thomas P Cappola,et al. Predictors of remodeling in the CRT era: influence of mitral regurgitation, BNP, and gender. , 2006, Journal of cardiac failure.
[7] Catherine Klersy,et al. Four-year efficacy of cardiac resynchronization therapy on exercise tolerance and disease progression: the importance of performing atrioventricular junction ablation in patients with atrial fibrillation. , 2006, Journal of the American College of Cardiology.
[8] Wojciech Zareba,et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. , 2009, The New England journal of medicine.
[9] J. Blanc,et al. Patients with non-ischaemic dilated cardiomyopathy and hyper-responders to cardiac resynchronization therapy: characteristics and long-term evolution. , 2009, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[10] David L Hayes,et al. Left ventricular lead position for cardiac resynchronization: a comprehensive cinegraphic, echocardiographic, clinical, and survival analysis. , 2012, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[11] Cynthia Balion,et al. BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review , 2014, Heart Failure Reviews.
[12] Wojciech Zareba,et al. Left Ventricular Ejection Fraction Normalization in Cardiac Resynchronization Therapy and Risk of Ventricular Arrhythmias and Clinical Outcomes: Results from the MADIT-CRT trial , 2014 .
[13] Cynthia Balion,et al. BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure , 2014, Heart Failure Reviews.
[14] Victor Mor-Avi,et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. , 2015, European heart journal cardiovascular Imaging.
[15] T. Imamura,et al. Reverse Remodeling Achieved by Combination Therapy With High-Dose Beta Blocker and Cardiac Resynchronization. , 2015, International heart journal.
[16] R. Borgquist,et al. Prediction of clinical outcome in patients treated with cardiac resynchronization therapy - the role of NT-ProBNP and a combined response score , 2018, BMC Cardiovascular Disorders.